Free On-line Access

SPCI - Sociedade Portuguesa de Cuidados Intensivos

Revista Brasileira de Terapia Intensiva

AMIB - Associação de Medicina Intensiva Brasileira


ISSN: 0103-507X
Online ISSN: 1982-4335

Ícone Fechar

How to Cite


Almeida TML, Azevedo LCP, Nosé PMG, Freitas FGR, Machado FR. Fatores de risco para desenvolvimento de agitação em pacientes críticos. Rev Bras Ter Intensiva. 2016;28(4):413-419





Risk factors for agitation in critically ill patients

Fatores de risco para desenvolvimento de agitação em pacientes críticos

Thiago Miranda Lopes de Almeida, Luciano Cesar Pontes de Azevedo, Paulo Maurício Garcia Nosé, Flavio Geraldo Resende de Freitas, Flávia Ribeiro Machado

Anesthesiology, Pain and Intensive Care Department, Escola Paulista de Medicina, Universidade Federal de São Paulo - Sao Paulo (SP), Brazil

Conflicts of interest: None.

Submitted on July 21, 2016
Accepted on September 21, 2016

Corresponding author: Thiago Miranda Lopes de Almeida, Anesthesiology, Pain and Intensive Care Department. Rua Napoleão de Barros, 737, 6º andar, Zip code: 04024-900 - São Paulo (SP), Brazil, E-mail: [email protected]



OBJECTIVE: To evaluate the incidence of agitation in the first 7 days after intensive care unit admission, its risk factors and its associations with clinical outcomes.
METHODS: This single-center prospective cohort study included all patients older than 18 years with a predicted stay > 48 hours within the first 24 hours of intensive care unit admission. Agitation was defined as a Richmond Agitation Sedation Scale score ≥ +2, an episode of agitation or the use of a specific medication recorded in patient charts.
RESULTS: Agitation occurred in 31.8% of the 113 patients. Multivariate analysis showed that delirium [OR = 24.14; CI95% 5.15 - 113.14; p < 0.001], moderate or severe pain [OR = 5.74; CI95% 1.73 - 19.10; p = 0.004], mechanical ventilation [OR = 10.14; CI95% 2.93 - 35.10; p < 0.001], and smoking habits [OR = 4.49; CI95% 1.33 - 15.17; p = 0.015] were independent factors for agitation, while hyperlactatemia was associated with a lower risk [OR = 0.169; CI95% 0.04 - 0.77; p = 0.021]. Agitated patients had fewer mechanical ventilation-free days at day 7 (p = 0.003).
CONCLUSION: The incidence of agitation in the first 7 days after admission to the intensive care unit was high. Delirium, moderate/severe pain, mechanical ventilation, and smoking habits were independent risk factors. Agitated patients had fewer ventilator-free days in the first 7 days.

Keywords: Psychomotor agitation; Risk factors; Delirium; Pain; Respiration, artificial; Intensive care.



Agitation in critically ill patients is a phenomenon that can compromise patient safety and assistance during intensive care unit (ICU) hospitalizations. It is characterized by increased motor and mental activity that manifests as inappropriate behavior, disorganized thoughts and a loss of self-control over actions. Agitation often masks diagnostics, delays treatment onset, which may have an impact on the morbidity and mortality of this population.(1-3)

The genesis of agitation is multifactorial.(4-6) Some medical conditions can coexist with or precede agitation episodes. These factors interact with the underlying disease and may increase the occurrence of hyperactivity episodes in the population.(1,3,7) Metabolic demand is increased during periods of agitation, which could compromise energy balance and precipitate organ dysfunction that, in turn, contributes to the loss of homeostasis among critically ill patients.(1) There is also an increased chance of self-extubation, removal of devices, falls and injuries in the presence of agitation.(8-11) Agitation is associated with a longer duration of mechanical ventilation (MV), an increased length of hospital and ICU stay, higher mortality rates and higher costs.(3,5,8,12-16)

The assessment of risk factors for agitation among critically ill patients may help understand its genesis and clinical context. This knowledge can provide a foundation for further clinical studies to test therapeutic and preventive strategies for agitation in the context of intensive care. Thus, the objectives of this study were to evaluate the incidence of agitation in the first seven days of intensive care unit admission, to identify the risk factors for its development and to assess its associations with poor clinical evolution.


This was a single-center, prospective cohort study conducted among patients admitted to a 17-bed general ICU at a university hospital. We included patients who were at least 18 years old within the first 24 hours of ICU admission and who had a predicted stay of more than 48 hours. Pregnant women, patients with previous psychiatric conditions, patients transferred from another ICU and those who had used haloperidol, dexmedetomidine, risperidone, or quetiapine prior to the study were excluded. The study was approved by the institution''s Research and Ethics Committee (655.838) without the need for informed consent due to its observational nature.

All patients were visited twice daily in the first 7 days of admission. In this prospective assessment, we considered agitated patients to be those with a Richmond Agitation Sedation Scale (RASS) score equal to or greater than +2.(17) We also retrospectively included those who had an episode of agitation recorded in their charts at any time during the day and those who received specific medications for agitation, such as quetiapine, risperidone, haloperidol or dexmedetomidine, which were exclusively used for agitation according to unit standards. All remaining subjects were considered non-agitated.

During the initial visit, we obtained baseline and demographic data as well as information on previous hospital stays, the type and reason for admission, patient origin, Charlson comorbidity index, presence of other comorbidities, Simplified Acute Physiology Score 3 (SAPS 3), and the Sequential Organ Failure Assessment (SOFA).(18) We also recorded the presence of multiple trauma, defined as trauma in more than two organs or systems, and severe brain injury, defined by a Glasgow Coma Score < 8 on arrival at the hospital.

During subsequent visits in the first 7 days, data were recorded on the clinical outcomes and potential risk factors for agitation. We administered the Confusion Assessment Method for Intensive Care Units (CAM-ICU)(19) and an analog pain scale twice a day. Patients with a RASS > 1 and a positive CAM-ICU were considered to have agitation secondary to hyperactive delirium. We considered pain to be moderate/severe when the score was greater than or equal to 3, within a range from 0 to 10. We documented all times when the scales could not be applied because of unresponsiveness. We also collected data on the SOFA score, use of anticholinergic medications,(20) sedatives, opioids or vasopressors, presence of pressure ulcers, sepsis,(21) acute respiratory distress syndrome,(22) hyperlactatemia (lactate > 14mg/dL), fever (axillary temperature > 37.8 °C) and the use of invasive devices. The need for MV and renal replacement therapy were also collected. We also recorded information about the presence of a clock in the room and the frequency of family visits.

Among patients without agitation, the total observation period was 7 days. Among agitated patients, only the variables present before the first episode of agitation were computed. We followed all patients until hospital discharge to assess the pre-defined outcomes. We analyzed ICU-free days and hospital-free days in 28 days, MV-free days and vasopressor-free days in the first 7 days, and ICU and hospital mortality.


The sample size was estimated considering a frequency of agitation of 25% among those exposed to risk factors and 10% among those not exposed. The required size was estimated to be 99 individuals based on a power of 80% and a 5% significance level in a 2-sided hypothesis test.(23) Comparisons of categorical variables were made using chi-square tests. Continuous variables were presented as the mean ± standard deviation or the median (interquartile range) according to the Kolmogorov-Smirnov normality test. We used Student''s t -test or Mann-Whitney U test to compare the variables between patients with and without agitation as appropriate. We selected variables in the univariate analysis with a p value below 0.05, and those considered clinically relevant were included in the multivariate analysis model using a backward stepwise selection procedure. The results of the multivariate analysis were expressed as odds ratios with 95% confidence intervals. We used Statistical Package for Social Science (SPSS) v. 22.0 for Windows (Chicago, IL, USA) for the statistical analysis. In all analyses, we considered p < 0.05 statistically significant.


Between April and August 2014, 302 patients were hospitalized at the ICU. Of these, 185 were excluded; the main reasons for exclusion are depicted in figure 1. We included 117 patients, and 4 were not analyzed due to incomplete data collection. Thus, our sample consisted of 113 patients. Their main baseline characteristics are described in table 1.

Figure 1 - Enrollment flowchart. ICU - intensive care unit.

Table 1 - Characteristics of the study population in the entire group according to agitation status
Variables All patients
(N = 113)
Not agitated
(N = 77)
(N = 36)
p value
Age (years) 55.2 ± 18.7 56.3 ± 17.0 52.7 ± 21.8 0.342
Male 63 (55.8) 40 (51.9) 23 (63.9) 0.234
Prior hospital stays (days) 3.0 (2.0 - 10.5) 3.0 (2.0 - 8.0) 2.0 (2.0 - 6.0) 0.777
Type of hospitalization        
    Clinic 31 (27.4) 21 (27.3) 10 (27.8) 0.955
    Elective surgery 31 (27.4) 22 (28.6) 9 (25.0) 0.691
    Urgent surgery 51 (45.1) 34 (44.2) 17 (47.2) 0.760
    Operating room 77 (68.1) 51 (66.2) 26 (72.2) 0.524
    Emergency room 19 (16.8) 13 (16.9) 6 (16.7) 0.977
    Ward 16 (14.2) 13 (16.9) 3 (8.3) 0.225
    Other 1 (0.9) 0 1 (2.8) 0.142
Reason for admission        
    Postoperative monitoring 49 (43.4) 36 (46.8) 13 (36.1) 0.288
    Sepsis 16 (14.2) 14 (18.2) 2 (5.6) 0.073
    Respiratory failure 11 (9.7) 8 (10.4) 3 (8.3) 0.731
    Acute neurological disease* 19 (16.8) 7 (9.1) 12 (33.3) 0.001
    Multiple trauma 4 (3.5) 4 (5.2) 0 0.164
    Other 14 (12.5) 8 (10.4) 6 (16.7) 0.451
SAPS 3 (points) 44.8 ± 15.2 46.2 ± 14.6 41.6 ± 16.3 0.139
SOFA at admission (points) 2.5 (1.0 - 5.2) 4.0 (2.0 - 7.0) 4.0 (2.0 - 7.0) 0.675
Charlson score (points) 4.0 ± 2.9 4.1 ± 2.8 3.9 ± 3.1 0.719
    Chronic renal failure 14 (12.4) 9 (11.7) 5 (13.9) 0.741
    Arterial hypertension 55 (48.7) 36 (46.8) 19 (52.8) 0.551
    Hearing impairment 11 (9.7) 5 (6.5) 6 (16.7) 0.089
    Visual impairment 41 (36.3) 25 (32.5) 16 (44.4) 0.217
    Alcohol abuse 20 (17.7) 10 (13.0) 10 (27.8) 0.055
    Tobacco use 23 (20.3) 11 (14.3) 12 (33.3) 0.019
    Diabetes mellitus 26 (23.0) 19 (24.7) 7 (19.4) 0.538
    COPD 11 (9.7) 7 (9.1) 4 (11.1) 0.736
Severe TBI 11 (9.7) 4 (5.2) 7 (19.4) 0.017
Glasgow at ICU admission 13.5 (10.0 - 14.0) 15.0 (14.0 - 15.0) 13.5 (10.0 - 14.0) < 0.001
Bed clock absent 83 (73.4) 57 (74) 26 (72.2) 0.840
Delirium 20 (17.7) 4 (5.2) 16 (44.4) < 0.001
Pain 60 (53.1) 37 (48.1) 23 (63.9) 0.116
Moderate to severe pain 48 (42.5) 27 (35.1) 21 (58.3) 0.020
MV use 57 (50.4) 30 (39.0) 27 (75.0) < 0.001
Sepsis 47 (41.6) 35 (45.5) 12 (33.3) 0.223
Vasopressor use 48 (42.5) 35 (45.5) 13 (36.1) 0.349
Hyperlactatemia 29 (25.7) 24 (31.2) 5 (13.9) 0.050
ARDS 11 (9.7) 10 (13.0) 1 (2.8) 0.088
RRT 11 (9.7) 8 (10.4) 3 (8.3) 0.731
Fever 22 (19.5) 18 (23.4) 4 (11.1) 0.125
Pressure ulcers 5 (4.4) 4 (5.2) 1 (3.2) 0.660
Family absent during visits 35 (31.0) 24 (31.2) 11 (30.6) 0.948
Invasive devices 106 (93.8) 72 (93.5) 34 (94.4) 0.847
Anticholinergic drugs 47 (41.6) 33 (42.9) 14 (38.9) 0.690
Sedatives and opioids 83 (73.4) 57 (76.0) 26 (72.2) 0.668

SAPS - Simplified Acute Physiology Score; SOFA - Sequential Organ Failure Assessment; COPD - chronic obstructive pulmonary disease; TBI - traumatic brain injury; ICU - intensive care unit; MV - mechanical ventilation; ARDS - acute respiratory distress syndrome; RRT - renal replacement therapy.

* Including ischemic or hemorrhagic stroke, subarachnoid hemorrhage, myasthenia and traumatic brain injury;

considering only patients under mechanical ventilation (N = 57) and vasopressors (N = 48). The results are expressed as the mean ± standard deviation, median (25% - 75%) or number (%). Chi-square or Student’s t-tests were used as appropriate.

Table 1 - Characteristics of the study population in the entire group according to agitation status

The incidence of agitation in the first 7 days of ICU hospitalization was 31.8%. The mean time to the onset of agitation was 2.4 ± 1.7 days. Among the agitated patients, the SOFA score on the agitation day was 4.0 (3.0 - 6.0). Pain and delirium could not be assessed in 57.1% and 53% of the attempts because of unresponsiveness. The univariate analysis showed that agitation was more frequent among patients who had a history of smoking, severe head injuries, hospitalization for acute neurological disease, moderate to severe pain, MV, and delirium. On the other hand, agitation was less frequent among patients with hyperlactatemia. There were no associations between the occurrence of agitation and age, severity of disease, SOFA and SAPS 3 scores, or hearing and visual impairment. These data are available in table 1.

The multivariate analysis included variables with a p ≤ 0.05 in the univariate analysis and those that were considered clinically relevant, namely, smoking, alcoholism, delirium, moderate or severe pain, MV and hyperlactatemia. As observed in table 2, the factors independently associated with a higher incidence of agitation were the presence of delirium, moderate or severe pain, MV, and smoking. The presence of hyperlactatemia remained a protective factor for agitation.

Table 2 - Risk factors for agitation in intensive care unit patients - multivariate analysis
Variable Odds ratio 95%CI p value
Smoking habit 4.49 1.33 - 15.17 0.015
Delirium 24.14 5.15 - 113.14 < 0.001
Moderate or severe pain 5.74 1.73 - 19.10 0.004
Mechanical ventilation 10.14 2.93 - 35.10 < 0.001
Hyperlactatemia 0.169 0.04 - 0.77 0.021

95%CI - 95% confidence interval. Backward stepwise selection procedure was used for the logistic regression - likelihood ratio. Hosmer and Lemeshow test: p = 0.102.

Table 2 - Risk factors for agitation in intensive care unit patients - multivariate analysis

Agitated patients had fewer MV free-days and lower hospital mortality than non-agitated patients (Table 3). However, after adjusting for age and SAPS 3 score, MV free-days remained significantly associated with the presence of agitation only, and hospital mortality was no longer significant [odds ratio 3.01; CI95% 0.89 - 10.26; p = 0.770].

Table 3 - Hospital outcomes according to agitation status
Variables Not agitated
(N = 77)
(N = 36)
p value
ICU-free days in 28 days 22.0 (11.5 - 24.5) 20.0 (12.0 - 23.0) 0.226
Hospital-free days in 28 days 9.0 (0 - 19.0) 11.0 (0 - 18.7) 0.228
MV-free days in 7 days 7.0 (3.5 - 7.0) 5.0 (1.2 - 6.7) 0.003
Vasopressor-free days in 7 days 7.0 (5.0 - 7.0) 7.0 (5.0 - 7.0) 0.495
ICU mortality 13 (17.1) 3 (8.3) 0.215
Hospital mortality 21 (28.4) 4 (11.1) 0.043

ICU - intensive care unit; MV - mechanical ventilation. Results are expressed as the number (%), mean ± standard deviation or median (25% - 75%). Chi-square or Student’s t-tests were used as appropriate.

Table 3 - Hospital outcomes according to agitation status


In this study, we found a high incidence of agitation in the first 7 days of ICU admission. In most cases, patients experienced agitation in the first 3 days after admission, and the factors associated with its occurrence were the presence of delirium, moderate or severe pain, MV, and a smoking habit. Patients with hyperlactatemia had a lower incidence of agitation. Agitated patients had fewer MV free-days.

The incidence of agitation in our study was lower than those previously reported in similar populations. Jaber et al. reported an agitation incidence of 52%,(5) while an even higher incidence (70%) was found by Fraser et al.(6) A higher incidence has also been reported in studies including patients under prolonged MV(5) and in critically ill clinical patients.(9) This variation may be due to differences in the criteria used to define agitation and the use of different diagnostic tools, as well as a longer observation period after ICU admission.

As expected, delirium was an independent risk factor for agitation in the first 7 days of ICU admission. In this time window, delirium occurred in 17.7% of the patients. This incidence was lower than that of other studies in critically ill patients because of our shorter duration of observation. Delirium is a highly prevalent condition in critically ill patients (20 - 80%).(22-30) Peterson et al.(30) reported a 71.5% prevalence of delirium, of which 54.9% were mixed type, showing that patients in ICUs frequently have moments of hyperactivity.(8,29-31)

However, we were able to identify other risk factors for agitation that were not related to the presence of delirium. This is a relevant finding, as a misdiagnosis of delirium can lead to inadequate treatment for both the underlying cause and for delirium itself. A previous habit of smoking is recognized as a risk factor for agitation, given the risk of withdrawal syndrome.(32,33) Lucidarme et al.,(32) in a study that included predominantly critically ill medical patients, showed that smokers had a higher incidence of agitation than non-smokers. Moderate or severe pain was more common among agitated patients. The majority of our studied patients were surgical (72.5%), which means that they had high exposures to pain in the first 7 days of observation. Previous studies that showed an association between pain and agitation did not assess whether the patient''s pain occurred before agitation.(13,34-38) In our study, we clearly showed that pain is a risk factor of agitation, as only episodes occurring before agitation were considered. MV was also associated with a higher risk of agitation, as previously reported by Woods et al.(9) Potential reasons for this association include the presence of the endotracheal tube, respiratory secretions and asynchrony with the ventilator. Patients under MV might not be able to communicate their needs to the healthcare team. The inability to communicate has previously been described as a risk factor for agitation.(11) In our unit, sedation was maintained as minimal as possible. Our finding suggests that the current no sedation or minimal sedation protocols need to also include a frequent assessment of pain and discomfort among patients using endotracheal tubes and MV.(39)

An unexpected finding was the lower incidence of agitation among patients with hyperlactatemia. Although we did not assess the potential mechanisms associated with this relationship, we can hypothesize that patients who develop tissue dysoxia may be more severely ill than those without signs of abnormal cellular metabolism.(18) More severe patients might require continuous long-term sedation, which can contribute to a lower incidence of agitation.(11) Another potential reason is the presence of neurological impairment or renal or hepatic dysfunction that could lead to a reduction in the level of consciousness, limiting the occurrence of agitation. The presence of neuromuscular weakness might also limit the clinical manifestation of agitation.

We were unable to show an association between age and agitation. Although age has been considered a risk factor for agitation, recent prospective studies have shown that age is a protective factor.(5,6,9) As delirium is frequent among agitated patients and among the elderly, it is possible that the prevalence of the hypoactive subtype among patients older than 65 years influences the potential association between age and agitation.(30) We were also not able to show an association between alcohol abuse and agitation. This relationship was expected, as abstinence is a well-known risk factor for agitation. The lack of association might be a consequence of the low prevalence of alcohol abuse among our patients.

Similar to other studies,(5,9) agitated patients had a longer duration of MV in the first 7 days, although no difference was found in hospital mortality.(5,9) We were unable to show an association between agitation and increased use of sedatives or higher severity of illness, which could possibly explain this finding. However, we can hypothesize that being agitated might have precluded attempts to discontinue MV, as suggested by others.(1)

This study has some strengths. First, we were able to prospectively determine the moment of agitation, and we were thus able to collect all data regarding risk factors before its occurrence. We consecutively followed all patients admitted to the ICU using a very careful assessment. However, it is worth highlighting some limitations. First, although we included the planned number of patients, studies with small sample sizes are subject to bias. Second, the consecutiveness of the inclusion procedure may have been compromised, as a third of the patients were excluded because they had been admitted for more than 24 hours, mostly on the weekends when the study team was not always available. This also led to a high incidence of missing data among the included patients. Third, the high frequency of MV also compromised the pain and delirium assessments. Fourth, we did not collect data on the presence of agitation during the patients'' entire ICU stay, which may have reduced our incidence of agitation. We also prospectively evaluated the presence of agitation only twice per day. The assessment of the entire day was conducted in a retrospective manner, and cases might have been missed. Additionally, we used the administration of antipsychotic drugs to define the presence of agitation. Although the use of these drugs is well controlled in our unit, misuse for other indications might have occurred. Finally, we did not collect data on agitation treatment, which might have influenced the outcome. However, this was not one of our objectives.

The results reinforce the fact that in addition to delirium, there are other independent risk factors for agitation among ICU patients. Good care practices, sedation, analgesia, and management of MV could reduce the incidence of agitation and provide benefits to patients admitted to the ICU.(11,20,40-45)


Agitation in the first 7 days of intensive care unit admission was common. The incidence of delirium, moderate or severe pain, mechanical ventilation, and smoking were independent risk factors for the development of agitation. The presence of agitation was associated with fewer mechanical ventilation-free days.


Chevrolet JC, Jolliet P. Clinical review: agitation and delirium in the critically ill--significance and management. Crit Care. 2007;11(3):214.
Crippen D. Agitation in the ICU: part one. Anatomical and physiologic basis for the agitated state. Crit Care. 1999;3(3):R35-46.
Zeller SL, Rhoades RW. Systematic reviews of assessment measures and pharmacologic treatments for agitation. Clin Ther. 2010;32(3):403-25.
Lindenmayer JP. The pathophysiology of agitation. J Clin Psychiatry. 2000;61 Suppl 14:5-10.
Jaber S, Chanques G, Altairac C, Sebbane M, Vergne C, Perrigault P, et al. A prospective study of agitation in a medical-surgical ICU: incidence, risk factors, and outcomes. Chest. 2005;128(4):2749-57.
Fraser GL, Prato BS, Riker RR, Berthiaume D, Wilkins ML. Frequency, severity, and treatment of agitation in young versus elderly patients in the ICU. Pharmacotherapy 2000;20(1):75-82.
Tramm R, Hodgson C, Ilic D, Sheldrake J, Pellegrino V. Identification and prevalence of PTSD risk factors in ECMO patients: A single center study. Aust Crit Care. 2015;28(1):31-6
Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291(14):1753-62.
Woods JC, Mion LC, Connor JT, Viray F, Jahan L, Huber C, et al. Severe agitation among ventilated medical intensive care unit patients: frequency, characteristics and outcomes. Intensive Care Med. 2004;30(6):1066-72.
Reade MC, O''Sullivan K, Bates S, Goldsmith D, Ainslie WR, Bellomo R. Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Crit Care. 2009;13(3):R75.
Barr J, Fraser GL, Puntillo K, Ely EW, Gélinas C, Dasta JF, Davidson JE, Devlin JW, Kress JP, Joffe AM, Coursin DB, Herr DL, Tung A, Robinson BR, Fontaine DK, Ramsay MA, Riker RR, Sessler CN, Pun B, Skrobik Y, Jaeschke R; American College of Critical Care Medicine. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263-306.
Capone Neto A, Dalfior Jr L. Fatores de risco. In: Flores DG, Capone Neto A. Delirium no paciente grave. São Paulo: Atheneu; 2013. p. 53-9.
O''Connor H, Al-Quadheeb NS, White AC, Thaker V, Devlin, JW. Agitation during prolonged mechanical ventilation at a long-term acute care hospital: risk factors, treatments and outcomes. J Intensive Care Med. 2014;29(4):218-24.
Ruokonen E, Parviainen I, Jakob SM, Nunes S, Kaukonen M, Shepherd ST, Sarapohja T, Bratty JR, Takala J; "Dexmedetomidine for Continuous Sedation" Investigators. Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med. 2009;35(2):282-90.
Xia ZQ, Chen SQ, Yao X, Xie CB, Wen SH, Liu KX. Clinical benefits of dexmedetomidine versus propofol in adult intensive care unit patients: a meta-analysis of randomized clinical trials. J Surg Res. 2013;185(2):833-43.
Wan RY, Kasliwal M, McKenzie CA, Nicholas NA. Quetiapine in refractory hyperactive and mixed intensive care delirium: a case series. Crit Care. 2011;15(3):R159.
Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O''Neal PV, Keane KA, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338-44.
Vincent JL, Moreno R, Takala J, Willats S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis - Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707-10.
Pessoa RF, Nácul FE. [Delirium in the critically ill patient]. Rev Bras Ter Intensiva. 2006;18(2):190-5. Portuguese. [Delirium in the critically ill patient].
Campbell N, Perkins A, Hui S, Khan B, Boustani M. Association between prescribing of anticholinergic medications and incident delirium: a cohort study. J Am Geriatr Soc. 2011;59 Suppl 2:S277-81.
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644-55. Review.
Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012;38(10):1573-82.
Lwanga SK, Lemeshow S. Sample size determination in health studies: a practical manual. Geneva: World Health Organization; 1991.
Salluh JI, Soares M, Teles JM, Ceraso D, Raimondi N, Nava VS, Blasquez P, Ugarte S, Ibanez-Guzman C, Centeno JV, Laca M, Grecco G, Jimenez E, Árias-Rivera S, Duenas C, Rocha MG; Delirium Epidemiology in Critical Care Study Group. Delirium epidemiology in critical care (DECCA): an international study. Crit Care. 2010;14(6):R210.
Khan BA, Zawahiri M, Campbell NL, Fox GC, Weinstein EJ, Nazir A, et al. Delirium in hospitalized patients: implications of current evidence on clinical practice and future avenues for research--a systematic evidence review. J Hosp Med. 2012;7(7):580-9.
Chorney SR, Gooch ME, Oberdier MT, Keating D, Stahl RF. The safety and efficacy of dexmedetomidine for postoperative sedation in the cardiac surgery intensive care unit. HSR Proc Intensive Care Cardiovasc Anesth. 2013;5(1):17-24.
Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911-22. Review.
Bryczkowski SB, Lopreiato MC, Yonclas PP, Sacca JJ, Mosenthal AC. Risk factors for delirium in older trauma patients admitted to the surgical intensive care unit. J Trauma Acute Care Surg. 2014;77(6):944-51.
Ouimet S, Kavanagh BP, Gottfried SB, Skrobi Y. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med. 2007;33(1):66-73.
Peterson JF, Pun BT, Dittus RS, Thomason JW, Jackson JC, Shintani AK, et al. Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc. 2006;54(3):479-84.
Blazer DG, Nieuwenhuizen AO. Evidence for the diagnostic criteria of delirium: an update. Curr Opin Psychiatry. 2012;25(3):239-43.
Lucidarme O, Seguin A, Daubin C, Ramakers M, Terzi N, Beck P, et al. Nicotine withdrawal and agitation in ventilated critically ill patients. Crit Care. 2010;14(2):R58.
Cohen IL, Gallagher TJ, Pohlman AS, Dasta, JF, Abraham E, Papadokos PJ. Management of the agitated intensive care unit patient. Crit Care Med. 2002;30(1):S97-123.
Luk E, Sneyers B, Rose L, Perreault MM, Williamsom DR, Mehta S, et al. Predictors of physical restraint use in Canadian intensive care units. Crit Care. 2014;18(2):R46.
Erstad BL, Puntillo K, Gilbert HC, Grap MJ, Li D, Medina J, et al. Pain management principles in the critically ill. Chest 2009 Apr;135(4):1075-86.
Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14(7):798-804.
Park JM, Kim JH. Assessment and treatment of pain in adult intensive care unit patients. Korean J Crit Care Med. 2014;29(3):147-59.
Rotondi AJ, Chelluri L, Sirio C, Mendelsohn A, Schulz R, Belle S, et al. Patients'' recollections of stressful experiences while receiving prolonged mechanical ventilation in an intensive care unit. Crit Care Med. 2002;30(4):746-52.
Shehabi Y, Bellomo R, Reade MC, Bailey M, Bass F, Howe B, McArthur C, Murray L, Seppelt IM, Webb S, Weisbrodt L; Sedation Practice in Intensive Care Evaluation Study Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Early goal-directed sedation versus standard sedation in mechanically ventilated critically ill patients: a pilot study. Crit Care Med. 2013;41(8):1983-91.
Holloman GH Jr, Zeller SL. Overview of Project BETA: Best practices in evaluation and treatment of agitation. West J Emerg Med. 2012;13(1):1-2.
Van Rompaey B, Elseviers MM, Schuurmans MJ, Shortridge-Baggett LM, Truijen S, Bossaert L. Risk factors for delirium in intensive care patients: a prospective cohort study. Crit Care. 2009;13(3):R77.
Teitelbaum JS, Ayoub O, Skrobik Y. A critical appraisal of sedation, analgesia and delirium in neurocritical care. Can J Neurol Sci. 2011;38(6):815-25.
Ely EW, Truman B, Shintani A, Thomason JW, Wheeler AP, Gordon S, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003;289(22):2983-91.
Zhang H, Lu Y, Liu M, Zou Z, Wang L, Xu FY, et al. Strategies for prevention of postoperative delirium: a systematic review and meta-analysis of randomized trials. Crit Care. 2013;17(2):R47.
Costa JB, Marcon SS, Macedo CR, Jorge AC, Duarte PA. Sedation and memories of patients subjected to mechanical ventilation in an intensive care unit. Rev Bras Ter Intensiva. 2014;26(2):122-9.

Responsible editor: Felipe Dal Pizzol

Submission On-line

Indexed in




Associação de Medicina Intensiva Brasileira - AMIB

Rua Arminda nº 93 - 7º andar - Vila Olímpia - São Paulo, SP, Brasil - Tel./Fax: (55 11) 5089-2642 | e-mail: [email protected]

GN1 - Systems and Publications